CN106821592A - Visual fatigue eyeshade and preparation method thereof for alleviating VDT syndromes - Google Patents
Visual fatigue eyeshade and preparation method thereof for alleviating VDT syndromes Download PDFInfo
- Publication number
- CN106821592A CN106821592A CN201710193637.0A CN201710193637A CN106821592A CN 106821592 A CN106821592 A CN 106821592A CN 201710193637 A CN201710193637 A CN 201710193637A CN 106821592 A CN106821592 A CN 106821592A
- Authority
- CN
- China
- Prior art keywords
- eyeshade
- precoat
- eyes
- pastille
- special
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000003464 asthenopia Diseases 0.000 title claims abstract description 28
- 208000011580 syndromic disease Diseases 0.000 title claims abstract description 27
- 238000002360 preparation method Methods 0.000 title abstract description 10
- 210000001508 eye Anatomy 0.000 claims abstract description 75
- 239000003814 drug Substances 0.000 claims abstract description 47
- 238000010438 heat treatment Methods 0.000 claims abstract description 44
- 235000010603 pastilles Nutrition 0.000 claims abstract description 43
- 210000005252 bulbus oculi Anatomy 0.000 claims abstract description 19
- 230000002093 peripheral effect Effects 0.000 claims abstract description 3
- 229940079593 drug Drugs 0.000 claims description 35
- 239000000835 fiber Substances 0.000 claims description 28
- 238000000034 method Methods 0.000 claims description 26
- 239000004744 fabric Substances 0.000 claims description 21
- 239000000284 extract Substances 0.000 claims description 18
- 239000000843 powder Substances 0.000 claims description 14
- 239000000463 material Substances 0.000 claims description 13
- 229920000297 Rayon Polymers 0.000 claims description 12
- 239000003292 glue Substances 0.000 claims description 12
- 239000002994 raw material Substances 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 11
- 239000004743 Polypropylene Substances 0.000 claims description 9
- 239000006185 dispersion Substances 0.000 claims description 9
- 239000012943 hotmelt Substances 0.000 claims description 9
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 8
- 238000009472 formulation Methods 0.000 claims description 8
- 235000007516 Chrysanthemum Nutrition 0.000 claims description 7
- 235000010254 Jasminum officinale Nutrition 0.000 claims description 7
- 244000046146 Pueraria lobata Species 0.000 claims description 7
- 235000010575 Pueraria lobata Nutrition 0.000 claims description 7
- 239000009759 San-Chi Substances 0.000 claims description 7
- 229920004933 Terylene® Polymers 0.000 claims description 7
- 239000002131 composite material Substances 0.000 claims description 7
- 239000005020 polyethylene terephthalate Substances 0.000 claims description 7
- 235000017166 Bambusa arundinacea Nutrition 0.000 claims description 6
- 235000017491 Bambusa tulda Nutrition 0.000 claims description 6
- 229920000742 Cotton Polymers 0.000 claims description 6
- 235000015334 Phyllostachys viridis Nutrition 0.000 claims description 6
- 229920001131 Pulp (paper) Polymers 0.000 claims description 6
- 239000011425 bamboo Substances 0.000 claims description 6
- -1 polypropylene Polymers 0.000 claims description 6
- 229920001155 polypropylene Polymers 0.000 claims description 6
- 239000002253 acid Substances 0.000 claims description 5
- 238000010422 painting Methods 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 4
- 240000008042 Zea mays Species 0.000 claims description 4
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 4
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 4
- 229920002678 cellulose Polymers 0.000 claims description 4
- 239000001913 cellulose Substances 0.000 claims description 4
- 235000005822 corn Nutrition 0.000 claims description 4
- 238000007731 hot pressing Methods 0.000 claims description 4
- 230000008595 infiltration Effects 0.000 claims description 4
- 238000001764 infiltration Methods 0.000 claims description 4
- 229920005989 resin Polymers 0.000 claims description 4
- 239000011347 resin Substances 0.000 claims description 4
- 150000003839 salts Chemical class 0.000 claims description 4
- 229910052711 selenium Inorganic materials 0.000 claims description 4
- 239000011669 selenium Substances 0.000 claims description 4
- 229910052902 vermiculite Inorganic materials 0.000 claims description 4
- 235000019354 vermiculite Nutrition 0.000 claims description 4
- 239000010455 vermiculite Substances 0.000 claims description 4
- 239000013013 elastic material Substances 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 238000003825 pressing Methods 0.000 claims description 2
- 238000004080 punching Methods 0.000 claims description 2
- 244000082204 Phyllostachys viridis Species 0.000 claims 2
- 244000189548 Chrysanthemum x morifolium Species 0.000 claims 1
- 240000005385 Jasminum sambac Species 0.000 claims 1
- 238000001467 acupuncture Methods 0.000 abstract description 3
- 238000012360 testing method Methods 0.000 description 9
- 238000002955 isolation Methods 0.000 description 7
- 241000723353 Chrysanthemum Species 0.000 description 6
- 241000207840 Jasminum Species 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 239000008194 pharmaceutical composition Substances 0.000 description 5
- 241001330002 Bambuseae Species 0.000 description 4
- 208000003556 Dry Eye Syndromes Diseases 0.000 description 4
- 206010013774 Dry eye Diseases 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000004745 nonwoven fabric Substances 0.000 description 3
- 230000002269 spontaneous effect Effects 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 206010034960 Photophobia Diseases 0.000 description 2
- 206010047513 Vision blurred Diseases 0.000 description 2
- 210000001742 aqueous humor Anatomy 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000008338 local blood flow Effects 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 238000010023 transfer printing Methods 0.000 description 2
- 208000005494 xerophthalmia Diseases 0.000 description 2
- 206010009185 Ciliary muscle spasm Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 238000004026 adhesive bonding Methods 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 206010005159 blepharospasm Diseases 0.000 description 1
- 230000000744 blepharospasm Effects 0.000 description 1
- 230000001886 ciliary effect Effects 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 210000004087 cornea Anatomy 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- SZGZILRQIYNODJ-UHFFFAOYSA-L disodium;7,12-dihydroquinoxalino[3,2-b]phenazine-2,9-disulfonate Chemical compound [Na+].[Na+].[O-]S(=O)(=O)C1=CC=C2N=C(C=C3C(NC4=CC=C(C=C4N3)S(=O)(=O)[O-])=C3)C3=NC2=C1 SZGZILRQIYNODJ-UHFFFAOYSA-L 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000000744 eyelid Anatomy 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000020169 heat generation Effects 0.000 description 1
- 206010023332 keratitis Diseases 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000001926 lymphatic effect Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 201000005111 ocular hyperemia Diseases 0.000 description 1
- 238000011017 operating method Methods 0.000 description 1
- 238000002577 ophthalmoscopy Methods 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 208000035824 paresthesia Diseases 0.000 description 1
- 238000007639 printing Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000009711 regulatory function Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 239000005439 thermosphere Substances 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/04—Eye-masks ; Devices to be worn on the face, not intended for looking through; Eye-pads for sunbathing
- A61F9/045—Eye-shades or visors; Shields beside, between or below the eyes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H39/00—Devices for locating or stimulating specific reflex points of the body for physical therapy, e.g. acupuncture
- A61H39/06—Devices for heating or cooling such points within cell-life limits
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/233—Bupleurum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M35/00—Devices for applying media, e.g. remedies, on the human body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H2201/00—Characteristics of apparatus not provided for in the preceding codes
- A61H2201/02—Characteristics of apparatus not provided for in the preceding codes heated or cooled
- A61H2201/0207—Characteristics of apparatus not provided for in the preceding codes heated or cooled heated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H2201/00—Characteristics of apparatus not provided for in the preceding codes
- A61H2201/10—Characteristics of apparatus not provided for in the preceding codes with further special therapeutic means, e.g. electrotherapy, magneto therapy or radiation therapy, chromo therapy, infrared or ultraviolet therapy
- A61H2201/105—Characteristics of apparatus not provided for in the preceding codes with further special therapeutic means, e.g. electrotherapy, magneto therapy or radiation therapy, chromo therapy, infrared or ultraviolet therapy with means for delivering media, e.g. drugs or cosmetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H2201/00—Characteristics of apparatus not provided for in the preceding codes
- A61H2201/16—Physical interface with patient
- A61H2201/1602—Physical interface with patient kind of interface, e.g. head rest, knee support or lumbar support
- A61H2201/1604—Head
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H2205/00—Devices for specific parts of the body
- A61H2205/02—Head
- A61H2205/022—Face
- A61H2205/024—Eyes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2207/00—Methods of manufacture, assembly or production
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2210/00—Anatomical parts of the body
- A61M2210/06—Head
- A61M2210/0612—Eyes
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Rehabilitation Therapy (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Anesthesiology (AREA)
- Ophthalmology & Optometry (AREA)
- Vascular Medicine (AREA)
- Physical Education & Sports Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention provides a kind of visual fatigue eyeshade for alleviating VDT syndromes; including eyeshade body and hangers rope; eyeshade body includes that the eyeball protection zone of human body eye can be covered and can cover the hot zone near the eyes of human body eye peripheral point; and near the pastille precoat of eyes side, the hot zone near the eyes is provided with special-shaped heating layer.Present invention also offers the preparation method of the visual fatigue eyeshade for alleviating VDT syndromes.Be combined together for acupuncture point hot compress and eyeshield medicine economic benefits and social benefits by the present invention, can effectively alleviate VDT syndromes.
Description
Technical field
The invention belongs to medical health field, specifically, the present invention relates to a kind of for alleviating regarding for VDT syndromes
Tired eyeshade and preparation method thereof.
Background technology
Video terminal syndrome VDT (Visual Display Terminal) refers to for a long time closely, is engaged in optics and shows
A series of syndromes caused by device terminal job.Cardinal symptom is hypopsia, blurred vision, ophthalmodynia, rubescent, photophobia, stream
Tear, eye are dry and astringent, headache, nausea etc..Due to the change of the modern life and working method, 50%~90% people can more or less go out
Existing VDT syndromes.
VDT syndromes produce main reason is that due to long-time eye, eye muscle (especially ciliary muscle) is in for a long time
Nervous contraction state, can cause ciliary spasm, it is impossible to recover regulatory function, can not be fully relaxed when remote thing is seen, so as to lead
The symptoms such as hypopsia are caused, secondly such as cornea is exposed in air for a long time, cause the decline of lacrimal secretion, tear film rupture
Time shortens, so as to trigger xerophthalmia, the dry, eye that goes out to lose face is puckery, the sour symptom such as swollen of eye.
The traditional Chinese medical science just has " mesh is liver key " theory from ancient times, and modern Chinese medicine thinks that the Etiological mechanism of visual fatigue is：Labor is regarded long
Grieved god, gas consumption damages blood, and mesh apoplex involving the channels and collaterals is not smooth, and caused by qi and blood does not fill, with regulating qi and dredging collateral in treatment, blood circulation promoting nourishes blood is principle.Knot
Traditional Chinese and western medicine theory is closed, can be by promoting local blood circulation near the eyes, nutrition local organization is alleviating visual fatigue.
Hot compress steam eye patch be at present be becoming increasingly popular on the market it is a kind of simple to operate, using comfortable, can be used to
Alleviate the product of visual fatigue, its cardinal principle is to stick on eye, by the constant hot compress of spontaneous heating (40-45 DEG C) 20-30 minutes,
So as to promote eye local circulation to reach the effect for alleviating visual fatigue.Product is single use, sanitory.
But with following several shortcomings：1st, there was only effect of single hot compress and steam release mostly, not with slow
The medicine or plant component for solving visual fatigue are combined；Though the 2, have being combined with drug ingedient on a small quantity, combination is generally in heating
Drug powder or extract are added in system, but due to the objective requirement of heat-generation system component ratio, the drug ingedient that can be added
Amount is few, and the easy equivalent risk that goes mouldy of drug ingedient；3rd, existing hot compress steam eye patch is using square structure (square
Or rectangle) covering eye include eyeball structure, constant temperature warming 20-30 minutes, due to the special physiological structure of aqueous humor in eyeball
It is the hot compress that needs avoid long-time and higher temperature with function, and existing hot compress steam eye patch is completely covered on the market
Eyeball position, such as control of product quality be not strict, can cause the potential risk of aqueous humor lesion.
The content of the invention
Therefore, to overcome disadvantages mentioned above of the prior art and deficiency, it is an object of the invention to provide one kind for delaying
Solve visual fatigue eyeshade of VDT syndromes and preparation method thereof.
Specifically, in order to solve the above technical problems, the present invention provides following technical scheme：
On the one hand, the present invention provides a kind of visual fatigue eyeshade for alleviating VDT syndromes, including eyeshade body and hangers
Rope, the eyeshade body includes：
The eyeball protection zone that human body eye can be covered and the hot zone near the eyes that human body eye peripheral point can be covered, and near eyes
The pastille precoat of side, the hot zone near the eyes is provided with special-shaped heating layer.
Preferably, according to foregoing eyeshade, the special-shaped heating layer includes outer bag and raw material layer, and the raw material layer sets
Put the side away from eyes in the pastille precoat.
Preferably, according to foregoing eyeshade, the outer bag has microporous breathable film, and/or
The raw material layer includes：One or more in iron powder, vermiculite, activated carbon, inorganic salts, water-absorbing resins, water.
Preferably, according to foregoing eyeshade, the eyeshade body further includes nexine and printed layer, the nexine
In the pastille precoat and the special-shaped heating layer near the side of eyes, the printed layer is in the pastille precoat and institute
Side of the special-shaped heating layer away from eyes is stated, and the raw material layer is located in the pastille precoat and the printed layer
Between；
It is further preferred that the printed layer is random or positioning prints required pattern.
Preferably, according to foregoing eyeshade, drug ingedient is attached on precoat by fabric attached medicine technique is formed
The pastille precoat, the fiber that the precoat is selected from one or more of high-selenium corn multiplying power mixes：It is wood pulp cellulose, pure
Cotton, acid fiber by polylactic, bamboo fibre, mucilaginous gum fiber, and the material of composite terylene or polypropylene fibre is made, the attached medicine technique of fabric
Including infiltration, sprinkling, turn to apply, and/or
The drug ingedient is using selected from one or more following formulation：Medicinal extract, extract solution and powder.
Preferably, according to foregoing eyeshade, hangers rope, the hangers are set in the left and right sides of the eyeshade body
Restrict and be made up of the adjustable elastic material for wearing length, the hangers rope is pressed together on the nexine by ultrasonic wave or hot melt.
On the other hand, the present invention provides a kind of method for producing the visual fatigue eyeshade for alleviating VDT syndromes, the side
Method includes making the following steps of eyeshade body：
By medical viscose glue or ultrasonic wave or hot melt, the outer of eyes side is close in the special-shaped heating layer of the eyeshade body
Any surface of bag or two sides pressing pastille precoat；
By viscose glue or painting print, the side by the special-shaped heating layer away from eyes is combined in printed layer；
By ultrasonic wave or bonding, the eyeshade nexine and the special-shaped heating layer near the side of eyes outer surface
Or the outer surface of the pastille precoat forms hot zone near the eyes；
By ultrasonic wave or hot pressing punching press, eyeball protection zone is formed in the pastille precoat and printed layer and nexine.
Preferably, also include according to method as described before, the step of the making eyeshade body：
Drug ingedient is attached on precoat by fabric attached medicine technique forms the pastille precoat, the fabric layer choosing
Mix from the fiber of one or more of high-selenium corn multiplying power：Wood pulp cellulose, pure cotton, acid fiber by polylactic, bamboo fibre, mucilaginous gum
The material of fiber and composite terylene or polypropylene fibre is made, and the attached medicine technique of fabric includes infiltration, sprinkling, turns to apply；And/or
The drug ingedient is using selected from one or more following formulation：Medicinal extract, extract solution and powder；
It is further preferred that methods described also includes：Hangers rope is pressed together on by the eyeshade sheet by ultrasonic wave or hot melt
On the nexine of body.
Preferably, according to method as described before, when the drug ingedient uses drug extract or drug extract formulation,
Fabric content of dispersion is no less than 1g/m2；Or
When the drug ingedient uses drug powder formulation, fabric content of dispersion is no less than 5g/m2。
Preferably, according to method as described before, the parts by weight proportioning of the drug ingedient is：25~30 parts of radix bupleuri,
20~30 parts of the root of kudzu vine, 10~30 parts of sanchi flower, 10~20 parts of chrysanthemum, 10~20 parts of Jasmine.
Compared with prior art, provided by the present invention for the visual fatigue eyeshade of alleviation VDT syndromes, with following excellent
Point：
1st, by setting the shape of heating layer, positioning covers the eye acupuncture point related to visual fatigue is alleviated, such as：Jingming,
Zanzhu, Yuyao, Sizhukong, chengqi, Sibai etc..
2nd, by constant hot compress, warm stimulates these acupuncture points, promotes local blood circulation and Lymphatic Circulation.
The 3rd, eyeball protection zone is set, it is to avoid eyeball is excessively heated.
The 4th, pastille precoat is set, and containing heat clearing and blood circulation promoting, tired eyeshield drug ingedient is delayed in improving eyesight, and effective component is steamed by water
Vapour release is carried over, and go directly eye, improves local organization nutrition, and dredging the channel, the promoting flow of qi and blood circulation makes to be reached in mesh so as to god in vital essence
Clear mesh is bright, alleviates VDT syndromes.
Brief description of the drawings
Hereinafter, embodiment of the present invention is described in detail with reference to accompanying drawing, wherein：
Fig. 1 shows side structure schematic diagram of the invention；
Fig. 2 shows the structural representation on the inside of eyeshade of the invention；
Fig. 3 shows the structural representation on the outside of eyeshade of the invention；
Description of reference numerals：
1st, pastille precoat；2nd, special-shaped heating layer, 2-1, special-shaped heating layer top, 2-2, special-shaped heating layer bottom；3rd, eye
Ball protection zone；4th, printed layer；5th, nexine；6th, hangers rope；7th, isolation pocket.
Specific embodiment
The present invention is further illustrated below by specific embodiment, it should be understood, however, that, these embodiments are only
It is used for specifically describing in more detail, and is not to be construed as limiting the present invention in any form.
This part to the present invention experiment used in material and test method carry out general description.Although being
Realize that many materials that the object of the invention used and operating method are it is known in the art that still the present invention still uses up herein
May describe in detail.It will be apparent to those skilled in the art that within a context, if not specified, material therefor of the present invention and behaviour
It is well known in the art as method.
Embodiment 1
The present embodiment is used to illustrate the structure for alleviating the visual fatigue eyeshade of VDT syndromes of the invention.
Referring to Fig. 1-3, Fig. 1 shows a kind of side structure schematic diagram for alleviating the visual fatigue eyeshade of VDT syndromes,
Including pastille precoat 1, special-shaped heating layer 2, eyeball protection zone 3, printed layer 4, nexine 5, hangers rope 6 and isolation pocket 7.
Pastille precoat 1 is pressed with special-shaped heating layer 2 near eyes side by medical viscose glue or ultrasonic wave or hot melt
Any surface of outer bag or two sides adhesion, special-shaped heating layer 2 are imprinted in printed layer 4 away from the side of eyes by gluing or painting, inner
Layer 5 is stamped and formed out hot zone 2 near the eyes, pastille precoat 1 near the side of eyes with special-shaped heating layer by ultrasonic wave or bonding
Eyeball protection zone 3 is stamped and formed out by ultrasonic wave or hot pressing with printed layer 4 and nexine 5, hangers rope 6 passes through ultrasonic wave or hot melt
Be pressed together on nexine 5, isolation pocket 7 be wrapped in pastille precoat 1, special-shaped heating layer 2, eyeball protection zone 3, printed layer 4, nexine 5,
Outside hangers rope 6.
Special-shaped heating layer 2 can be constituted using spontaneous heating filling bag, and spontaneous heating filling bag is made up of outer bag and raw material layer, outer bag
With microporous breathable film, raw material layer includes one or more in iron powder, vermiculite, activated carbon, inorganic salts, water-absorbing resins, water,
Special-shaped heating layer 2 is bonded in printed layer 4 away from the outer bag of eyes side by adhesive, also can be by transfer printing process by raw material
Layer (including iron powder, vermiculite, activated carbon, inorganic salts, water-absorbing resins, water etc.) is applied and is imprinted in printed layer 4.
Printed layer 4 can use non-woven fabrics material, such as PE, PP, PVC etc. to be made, can random in printed layer 4 or positioning
Pattern needed for printing.
Nexine 5 can use non-woven fabrics material, such as PE, PP, PVC etc. and/or mixed plant fiber to be made, soft pro-skin,
Using comfortable.
Hangers rope 6 is elastic material, is made up of non-woven fabrics material, including but not limited to：PE, PP, PVC etc., by elasticity
Regulation is worn length and is used with being adapted to different crowd.
Isolation pocket 7 uses conventional medical isolation pocket, with good isolation from oxygen effect.
When using, isolation pocket is torn, hot compress steam eye patch is taken out, by hangers rope sling after auricle, adjust eyeshade and eye
Fitted at portion and the bridge of the nose.
Embodiment 2
The present embodiment is used to illustrate the preparation method for alleviating the visual fatigue eyeshade of VDT syndromes of the invention.
Weigh the drug component of following parts by weight：25 parts of radix bupleuri, 28 parts of the root of kudzu vine, 15 parts of sanchi flower, 15 parts of chrysanthemum, jasmine
15 parts are spent, the pharmaceutical composition is then fabricated to medicinal extract, the drug extract that will be made by infiltrating technique is attached to fine by wood pulp
On the precoat that dimension composite terylene is made, fabric content of dispersion is 1.5g/m2, obtain pastille precoat.
In special-shaped heating layer near the outer surface of the outer bag of eyes side by medical viscose glue adhesion pastille precoat, abnormity
Heating layer is sticked in printed layer away from the outer bag of eyes side by viscose glue, and nexine is with the excessively special-shaped heating layer of adhesion containing powder
The bed of material forms hot zone near the eyes by bonding, and pastille precoat is protected by ultrasonic waveform with printed layer and nexine into eyeball
Area, passes through ultrasonic compressing hangers rope on nexine.
Embodiment 3
The present embodiment is used to illustrate the preparation method for alleviating the visual fatigue eyeshade of VDT syndromes of the invention.
Weigh the drug component of following parts by weight：30 parts of radix bupleuri, 30 parts of the root of kudzu vine, 16 parts of sanchi flower, 12 parts of chrysanthemum, jasmine
12 parts are spent, the pharmaceutical composition is then fabricated to extract solution, the drug extract that will be made by spray processing is attached to by wood
On the precoat that pulp fibres, acid fiber by polylactic, the mixing of mucilaginous gum fiber and composite terylene are made, fabric content of dispersion is 2.5g/
m2, obtain pastille precoat.
Pastille precoat, abnormity are pressed by medical hot melt near the inner surface of the outer bag of eyes side in special-shaped heating layer
The raw material layer of heating layer is applied by transfer printing process and is imprinted in printed layer, the outer bag of nexine and special-shaped heating layer near the side of eyes
Outer surface hot zone near the eyes is stamped and formed out by hot pressing, pastille precoat is with printed layer and nexine by ultrasonic waveform into eye
Ball protection zone, passes through ultrasonic compressing hangers rope on nexine.
Embodiment 4
The present embodiment is used to illustrate the preparation method of visual fatigue eyeshade of the present invention for alleviating VDT syndromes.
Weigh the drug component of following parts by weight：28 parts of radix bupleuri, 20 parts of the root of kudzu vine, 28 parts of sanchi flower, 14 parts of chrysanthemum, jasmine
10 parts are spent, the pharmaceutical composition is then fabricated to powder, the drug powder that will be made by turning painting technique is attached to by pure cotton, bamboo
Fiber, mucilaginous gum fiber mix and are combined on the precoat that polypropylene fibre is made, and fabric content of dispersion is 7g/m2, obtain pastille fabric
Layer.
In special-shaped heating layer near the outer surface of the outer bag of eyes side by ultrasonic compressing pastille precoat, abnormity hair
Thermosphere is sticked in printed layer away from the outer bag of eyes side by viscose glue, the pastille fabric of nexine and the excessively special-shaped heating layer of adhesion
Layer is stamped and formed out hot zone near the eyes by ultrasonic wave, and pastille precoat is protected by ultrasonic waveform with printed layer and nexine into eyeball
Shield area, passes through ultrasonic compressing hangers rope on nexine.
Embodiment 5
The present embodiment is used to illustrate the preparation method for alleviating the visual fatigue eyeshade of VDT syndromes of the invention.
Weigh the drug component of following parts by weight：25 parts of radix bupleuri, 25 parts of the root of kudzu vine, 10 parts of sanchi flower, 20 parts of chrysanthemum, jasmine
20 parts are spent, the pharmaceutical composition is then fabricated to medicinal extract, the drug extract that will be made by infiltrating technique is attached to fine by wood pulp
On the precoat that dimension composite terylene is made, fabric content of dispersion is 1g/m2, obtain pastille precoat.
In special-shaped heating layer near the outer surface of the outer bag of eyes side by medical viscose glue adhesion pastille precoat, abnormity
Heating layer is sticked in printed layer away from the outer bag of eyes side by viscose glue, and nexine is with the excessively special-shaped heating layer of adhesion containing powder
The bed of material forms hot zone near the eyes by bonding, and pastille precoat is protected by ultrasonic waveform with printed layer and nexine into eyeball
Area, passes through ultrasonic compressing hangers rope on nexine.
Embodiment 6
The present embodiment is used to illustrate the preparation method for alleviating the visual fatigue eyeshade of VDT syndromes of the invention.
Weigh the drug component of following parts by weight：25 parts of radix bupleuri, 25 parts of the root of kudzu vine, 30 parts of sanchi flower, 10 parts of chrysanthemum, jasmine
10 parts are spent, the pharmaceutical composition is then fabricated to powder, the drug powder that will be made by spray processing is attached to by pure cotton, bamboo
Fiber, mucilaginous gum fiber mix and are combined on the precoat that polypropylene fibre is made, and fabric content of dispersion is 15g/m2, obtain pastille fabric
Layer.
In special-shaped heating layer near the outer surface of the outer bag of eyes side by medical viscose glue adhesion pastille precoat, abnormity
Heating layer is sticked in printed layer away from the outer bag of eyes side by viscose glue, and nexine is with the excessively special-shaped heating layer of adhesion containing powder
The bed of material forms hot zone near the eyes by bonding, and pastille precoat is protected by ultrasonic waveform with printed layer and nexine into eyeball
Area, passes through ultrasonic compressing hangers rope on nexine.
Test example 1
This test example be used for illustrate it is of the invention for alleviate the visual fatigue eyeshade of VDT syndromes to visual fatigue effect.
Test method
Clinical funduscopy, excludes infected keratitis, eye wound, operated eye, eye local patholoic change, LADA
Disease, long-term the whole province or ophthalmic administration patient.71 subjects, 45 women, 26 males are filtered out altogether；Age is：20-57
In year, average age is：27.90±9.21.
Eye surface diseases judgement (OSDI) index test, including common 12 kinds of symptom ranks are carried out to above-mentioned subject：Dry and astringent,
Foreign body sensation, shouting pain/distending pain, blurred vision (after blink take a turn for the better), photophobia, secretion increases, sheds tears, eyelid sense of heaviness, eye are itched, eye
Red, asthenopia and blepharospasm.All subjects fill in paresthesia inquiry schedule under same guidance.The occurrence frequency of every kind of symptom
Every kind of symptom is divided into 4 ranks, the dry eye condition that different fractions judge its VDT syndrome is counted.
Breakup time of tear film test is carried out to above-mentioned subject, is repeated 3 times, record and calculate average value.
The test of Schirmer ' s I tear length is carried out to above-mentioned subject and is recorded.
Then, the visual fatigue eyeshade for being prepared using the method for the present embodiment 2, the test for allowing subject to carry out 2 weeks by a definite date, often
It is used 1 time, and 1 time one secondary, each 20min, altogether 14 times.
Result of the test
Eye surface diseases index (OSDI) has obvious reduction, and decreasing value is 9.87, normal 39 people, mild dry eye 23
People, the people of moderate xerophthalmia 7, the people of severe dry eye 2；
In breakup time of tear film test, left eye breakup time of tear film extension 1.41, right eye breakup time of tear film extension 1.8；
In Schirmer ' s I tear length testings, left eye tear length increases 5.92cm, and right eye tear length increases
5.94cm.
Visual fatigue measure of merit conclusion is shown, after eyeshade of the present invention, VDT syndromes are relieved, mainly
Show as including the improvement of sense of fatigue and the improvement of dry eye condition.
Although present invention has been a certain degree of description, it will be apparent that, do not departing from the spirit and scope of the present invention
Under the conditions of, the appropriate change of each condition can be carried out.It is appreciated that the invention is not restricted to the embodiment, and it is attributed to right
It is required that scope, its equivalent for including each factor.
Claims (10)
1. a kind of visual fatigue eyeshade for alleviating VDT syndromes, including eyeshade body and hangers rope, it is characterised in that described
Eyeshade body includes：
The eyeball protection zone that human body eye can be covered and the hot zone near the eyes that human body eye peripheral point can be covered, and near eyes side
Pastille precoat, the hot zone near the eyes is provided with special-shaped heating layer.
2. eyeshade according to claim 1, it is characterised in that the special-shaped heating layer includes outer bag and raw material layer, described
Raw material layer is arranged on side of the pastille precoat away from eyes.
3. eyeshade according to claim 2, it is characterised in that：
The outer bag has microporous breathable film, and/or
The raw material layer includes：One or more in iron powder, vermiculite, activated carbon, inorganic salts, water-absorbing resins, water.
4. the eyeshade according to claim any one of 1-3, it is characterised in that the eyeshade body further include nexine and
Printed layer, in the pastille precoat and the special-shaped heating layer near the side of eyes, the printed layer is in institute for the nexine
State the side of pastille precoat and the special-shaped heating layer away from eyes, and the raw material layer be located at the pastille precoat and
The centre of the printed layer；
Preferably, the printed layer is random or positioning prints required pattern.
5. the eyeshade according to claim any one of 1-4, it is characterised in that：
Drug ingedient is attached on precoat by fabric attached medicine technique forms the pastille precoat, the precoat be selected from
The fiber mixing of lower one or more high-selenium corn multiplying power：Wood pulp cellulose, pure cotton, acid fiber by polylactic, bamboo fibre, mucilaginous gum are fine
Tie up, and the material of composite terylene or polypropylene fibre is made, the attached medicine technique of fabric includes infiltration, sprinkling, turns painting, and/or
The drug ingedient is using selected from one or more following formulation：Medicinal extract, extract solution and powder.
6. the eyeshade according to claim any one of 1-5, it is characterised in that set in the left and right sides of the eyeshade body
Hangers rope, the elastic material that the hangers rope wears length by can adjust is made, and the hangers rope is by ultrasonic wave or hot melt pressure
Close on the nexine.
7. a kind of method for producing the visual fatigue eyeshade for alleviating VDT syndromes, it is characterised in that methods described includes making
The following steps of eyeshade body：
By medical viscose glue or ultrasonic wave or hot melt, the outer bag of eyes side is close in the special-shaped heating layer of the eyeshade body
Any surface or two sides pressing pastille precoat；
By viscose glue or painting print, the side by the special-shaped heating layer away from eyes is combined in printed layer；
By ultrasonic wave or bonding, the outer surface with the special-shaped heating layer near the side of eyes or institute in the eyeshade nexine
The outer surface for stating pastille precoat forms hot zone near the eyes；
By ultrasonic wave or hot pressing punching press, eyeball protection zone is formed in the pastille precoat and printed layer and nexine.
8. method according to claim 7, it is characterised in that also include the step of the making eyeshade body：
Drug ingedient is attached on precoat by fabric attached medicine technique forms the pastille precoat, the precoat be selected from
The fiber mixing of lower one or more high-selenium corn multiplying power：Wood pulp cellulose, pure cotton, acid fiber by polylactic, bamboo fibre, mucilaginous gum fiber
And the material of composite terylene or polypropylene fibre is made, the attached medicine technique of fabric includes infiltration, sprinkling, turns to apply；And/or
The drug ingedient is using selected from one or more following formulation：Medicinal extract, extract solution and powder；
Preferably, methods described also includes：Hangers rope is pressed together on the nexine of the eyeshade body by ultrasonic wave or hot melt.
9. method according to claim 8, it is characterised in that：
When the drug ingedient uses drug extract or drug extract formulation, fabric content of dispersion is no less than 1g/m2；Or
When the drug ingedient uses drug powder formulation, fabric content of dispersion is no less than 5g/m2。
10. method according to claim 8 or claim 9, it is characterised in that the parts by weight proportioning of the drug ingedient is：Bavin
25~30 parts recklessly, 20~30 parts of the root of kudzu vine, 10~30 parts of sanchi flower, 10~20 parts of chrysanthemum, 10~20 parts of Jasmine.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710193637.0A CN106821592A (en) | 2017-03-28 | 2017-03-28 | Visual fatigue eyeshade and preparation method thereof for alleviating VDT syndromes |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710193637.0A CN106821592A (en) | 2017-03-28 | 2017-03-28 | Visual fatigue eyeshade and preparation method thereof for alleviating VDT syndromes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106821592A true CN106821592A (en) | 2017-06-13 |
Family
ID=59142503
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710193637.0A Pending CN106821592A (en) | 2017-03-28 | 2017-03-28 | Visual fatigue eyeshade and preparation method thereof for alleviating VDT syndromes |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106821592A (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107456316A (en) * | 2017-08-31 | 2017-12-12 | 广西巧恩茶业有限公司 | A kind of preparation method of jasmine tea bamboo charcoal eyepatch |
| CN108743027A (en) * | 2018-05-15 | 2018-11-06 | 威莱(广州)日用品有限公司 | A kind of steam eye patch and preparation method thereof |
| CN109771809A (en) * | 2019-03-13 | 2019-05-21 | 郑州佶好生物科技有限公司 | A kind of improving eyesight eyeshield health-care patch and preparation method thereof |
| CN110090106A (en) * | 2019-05-10 | 2019-08-06 | 曲中周 | A kind of eyeshade adjusting eyesight |
| WO2020231343A1 (en) * | 2019-05-16 | 2020-11-19 | National University Of Singapore | Eye mask |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102846430A (en) * | 2012-09-29 | 2013-01-02 | 天津世济生物工程有限公司 | Health-care eyeshade |
| CN103190984A (en) * | 2013-04-11 | 2013-07-10 | 天津富勤科技有限公司 | Steam heat eye mask |
| CN105079952A (en) * | 2015-08-14 | 2015-11-25 | 张航铭 | Eye paste with healthcare function |
| CN105534641A (en) * | 2016-01-06 | 2016-05-04 | 天津富勤科技有限公司 | Self-heating health-care eye patch |
| CN105616758A (en) * | 2016-01-31 | 2016-06-01 | 蕲春时珍本草科技有限公司 | Traditional Chinese medicine concentrated solution and eye mask for eye healthcare |
| CN105616757A (en) * | 2016-01-31 | 2016-06-01 | 湖北蕲艾堂科技有限公司 | Traditional Chinese medicine powder bag and eye mask for eye healthcare |
| CN106420156A (en) * | 2016-10-21 | 2017-02-22 | 广州市科能化妆品科研有限公司 | Self-heating paster |
| CN208974301U (en) * | 2017-03-28 | 2019-06-14 | 云南白药集团股份有限公司 | For alleviating the drug containing acupuncture point hot compress steam eye patch of VDT syndrome |
-
2017
- 2017-03-28 CN CN201710193637.0A patent/CN106821592A/en active Pending
Patent Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102846430A (en) * | 2012-09-29 | 2013-01-02 | 天津世济生物工程有限公司 | Health-care eyeshade |
| CN103190984A (en) * | 2013-04-11 | 2013-07-10 | 天津富勤科技有限公司 | Steam heat eye mask |
| CN105079952A (en) * | 2015-08-14 | 2015-11-25 | 张航铭 | Eye paste with healthcare function |
| CN105534641A (en) * | 2016-01-06 | 2016-05-04 | 天津富勤科技有限公司 | Self-heating health-care eye patch |
| CN105616758A (en) * | 2016-01-31 | 2016-06-01 | 蕲春时珍本草科技有限公司 | Traditional Chinese medicine concentrated solution and eye mask for eye healthcare |
| CN105616757A (en) * | 2016-01-31 | 2016-06-01 | 湖北蕲艾堂科技有限公司 | Traditional Chinese medicine powder bag and eye mask for eye healthcare |
| CN106420156A (en) * | 2016-10-21 | 2017-02-22 | 广州市科能化妆品科研有限公司 | Self-heating paster |
| CN208974301U (en) * | 2017-03-28 | 2019-06-14 | 云南白药集团股份有限公司 | For alleviating the drug containing acupuncture point hot compress steam eye patch of VDT syndrome |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107456316A (en) * | 2017-08-31 | 2017-12-12 | 广西巧恩茶业有限公司 | A kind of preparation method of jasmine tea bamboo charcoal eyepatch |
| CN108743027A (en) * | 2018-05-15 | 2018-11-06 | 威莱(广州)日用品有限公司 | A kind of steam eye patch and preparation method thereof |
| CN108743027B (en) * | 2018-05-15 | 2019-11-01 | 威莱(广州)日用品有限公司 | A kind of steam eye patch and preparation method thereof |
| CN109771809A (en) * | 2019-03-13 | 2019-05-21 | 郑州佶好生物科技有限公司 | A kind of improving eyesight eyeshield health-care patch and preparation method thereof |
| CN109771809B (en) * | 2019-03-13 | 2021-05-14 | 郑州佶好生物科技有限公司 | Eyesight-improving eye-protecting health-care patch and manufacturing method thereof |
| CN110090106A (en) * | 2019-05-10 | 2019-08-06 | 曲中周 | A kind of eyeshade adjusting eyesight |
| WO2020231343A1 (en) * | 2019-05-16 | 2020-11-19 | National University Of Singapore | Eye mask |
| CN113840584A (en) * | 2019-05-16 | 2021-12-24 | 新加坡国立大学 | Eye cover |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106821592A (en) | Visual fatigue eyeshade and preparation method thereof for alleviating VDT syndromes | |
| CN205515139U (en) | Chinese mugwort essential oil physiotherapy subsides | |
| CN102552714B (en) | Plaster for treating facial neuroparalysis and rheumatic arthritis | |
| CN106214331B (en) | A kind of reusable steam heat eye mask | |
| CN102008596B (en) | Chinese medicine eye compressing bag for treating myopic eye | |
| CN107050227A (en) | A kind of herbal essences combination eye sticker and preparation method for treating eye visual fatigue disease | |
| CN208756312U (en) | A kind of middle Medical eye cover | |
| CN110478122A (en) | A kind of pure Chinese medicine eyeshade and preparation method thereof curing mainly visual fatigue | |
| CN103767420A (en) | Cervical vertebra health care pillow having recovery effects on mixed type cervical spondylosis | |
| KR20100126987A (en) | Hanji sanitary pad containing medicinal herbs | |
| CN208974301U (en) | For alleviating the drug containing acupuncture point hot compress steam eye patch of VDT syndrome | |
| CN208710249U (en) | A kind of new medical eye sticker | |
| CN103054986A (en) | Traditional Chinese medicine and traditional Chinese medicine pillow capable of curing sleeplessness | |
| CN207041013U (en) | A kind of new type of health sport cap | |
| CN109077927A (en) | A kind of spontaneous heating moxa-moxibustion eyeshade | |
| CN109077924A (en) | A kind of moxa-moxibustion mud emplastrum | |
| CN206700305U (en) | A kind of hot compress eye-mask with circular cavity | |
| CN203915223U (en) | A kind of eyeshield | |
| CN210096069U (en) | Self-heating eye patch containing Chinese medicinal herbs | |
| CN106075340A (en) | The Chinese medicine composition for the treatment of osteoarthritis and the Chinese medicine patch for the treatment of osteoarthritis | |
| CN209475153U (en) | A kind of dedicated moxibustion plaster of knee joint | |
| CN107412539A (en) | Prevent and treat the herbal application of myopia | |
| CN106729575A (en) | With teenager's anti-inflammation, the Chinese medicine composition of acne-removing and skin-clearing effect, cosmetics and preparation method thereof | |
| CN101199732A (en) | Mud plaster medicament for treating corn | |
| EP1838262B1 (en) | Linseed eye compresses |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170613 |
|
| RJ01 | Rejection of invention patent application after publication |